ACM
GOSS icon

Altium Capital Management’s Gossamer Bio GOSS Stock Holding History

Altium Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-135,000
Closed -$1.62M – 109
2022
Q3 		$1.62M Sell
135,000
-125,000
-48% -$1.55M 0.59% 68
2022
Q2 		$2.18M Buy
+260,000
New +$2.01M 0.87% 47

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Altium Capital Management's GOSS Position: Q4 2022 in Review

Altium Capital Management sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 135,000 shares — an estimated $1.62M sold.

Altium Capital Management first reported a position in GOSS in Q2 2022 and held it in 2 quarters. The position peaked at $2.18M in Q2 2022. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Altium Capital Management reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Altium Capital Management sold 135,000 Gossamer Bio shares in Q4 2022, an estimated $1.62M.
  • Altium Capital Management first reported a position in Gossamer Bio in Q2 2022 and held it in 2 quarters.
  • Altium Capital Management's Gossamer Bio position peaked at $2.18M in Q2 2022.
  • 120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Altium Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.